Key points are not available for this paper at this time.
Platelet Intracellular Calcium and the Response to Serotonin as a Peripheral Marker in Mood Disorders (M. Berk). Stress, Glucocorticoids and Depression: Implications for Pharmacological Intervention (T. Dinan). Measuring Cholinergic Function and Cognitive Abilities (W. Riedel, et al.). Assessing Sedating and Alerting Drug Effects: The Multiple Sleep Latency Test (T. Roth & T. Roehrs). Actigraphy in Psychopharmacology (N. Stanley). Cognitive Testing of New Anticonvulsants (M. Trimble). Vascular Dementia: Diagnosis and Management (K. Amar & G. Wilcock). Quality of Life in Psychopharmacology: What are We Measuring and Why Does it Matter? (C. Selai & M. Trimble). Drug Regulation and Psychopharmacology: Measures and Methods (D. Jefferys). Assessing Accident Risk Potential for Psychoactive Drugs (C. Dal Pozzo). Legal Aspects of Drugs in the Workplace (G. Howard). Withdrawal of Psychotropic Drugs from the Market: I: From Thalidomide to Zimeldine (J. Edwards). Withdrawal of Psychotropic Drugs from the Market: II: From Nomifensine to Remoxipride (J. Edwards). Index.
Hindmarch et al. (Mon,) studied this question.